| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 700/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Acetyl Carnosine |
| Appearance | White Powder |
| CAS | 56353-15-2 |
| MF | C11h16n4o4 |
| MW | 268273 |
Antioxidant effect
The effective treatment of cataracts with N-acetylcarnitine and non hydrolyzed carnitine is due to its antioxidant properties. Oxidation refers to the phenomenon in which cells are damaged due to excessive reactive oxygen species.
Inhibit the antioxidant function of this oxidation. It is a natural amino acid called myopeptide.
When the human body produces this peptide, cataracts can be inhibited. The decline in this generation function is the direct cause of cataracts. However, N-acetylcarnosine and non hydrolyzed carnosine can be supplemented by humans. This is how people use N
Acetylcarnitine and non hydrolyzed carnitine have antioxidant effects.
Anti glycation effect
Saccharification refers to the denaturation of substances such as proteins and fats that react with sugar.
Saccharification not only causes diabetes, but also various chronic diseases, such as hypertension, cataract, kidney disease, Alzheimer's disease, decreased immunity, etc., which must be noted.
There are anti glycation substances for this type of saccharification. This is a type of myopeptide produced by chemical synthesis of amino acids L-histidine and β - alanine, which has the characteristic of being converted into the original myopeptide in the body. By utilizing this characteristic, Clara Steele, a cataract eye drops containing human N-acetylcarnosine and non hydrolyzed carnosine, has improved the effectiveness of cataract treatment.
){kind=link}